Efficacy and safety of anlotinib in patients with unresectable or metastatic well-differentiated/dedifferentiated liposarcoma: a single-center retrospective study.

Autor: Zhi-Ke Li, Jie Liu, Yao-Tiao Deng, Yu Jiang
Zdroj: Anti-Cancer Drugs; Feb2021, Vol. 32 Issue 2, p210-214, 5p
Databáze: Complementary Index